針の中の水銀:悪意のある注射と毒性のケース

Naghmeh Kian¹, Mitra Rahimi², Shahin Shadnia²

¹School of Medicine Shahid Beheshti University of Medical Sciences Tehran Iran.

Clinical case reports

|February 13, 2026

まとめ

このケースレポートは,皮下注射による水銀毒性の希少な事例を詳細に説明しています. 一人の女性は注射後,のレベルが高く,全身的な症状はほとんどなく,異常なプレゼンテーションと治療反応を強調する gluteal 病変を発症しました.

科学分野:

毒理学毒理学毒理学
皮膚科皮膚科について
ケースレポートケースレポート

背景:

水銀の毒性は,通常,摂取または吸入によって引き起こされます.
皮下水銀注射は極めてまれで,しばしば事故的または意図的な自己傷害に関連しています.
報告された症例は,通常,痛みを伴う小粒腫と,まれに全身的関与を伴う.

研究の目的:

皮下注射による水銀毒性のユニークな症例を報告する.
この希少な疾患の臨床表現,診断結果,治療について説明します.
異例の曝露経路の可能性と,水銀中毒の意図について議論する.

主な方法:

39歳の女性患者の詳細な臨床症例紹介.
患者の病歴,身体検査の結果,検査結果 (血清水銀濃度) の分析.
サクシマーによる治療のドキュメントと,その後の臨床結果.

主要な成果:

患者は,注射を受けた後,水銀を含む局所的で痛ましい臓病変を呈した.
血清水銀レベルは,最小限の全身症状にもかかわらず, (345μg/L) 大きく上昇しました.
サクシマーによる治療は,水銀濃度の低下につながった.

結論:

皮下水銀注射は局所的な毒性をもたらし,驚くほど低い全身的症状を引き起こす可能性があります.
このケースは,水銀中毒の希少な事例であり,潜在的に殺人意図を含む可能性があります.
迅速な診断とケレーション治療は,暴露経路に関係なく,水銀の毒性の管理に不可欠です.

キーワード:

インジェクション・インジェクション水銀は水銀である.皮下注射は皮下注射として行われます.症状症状症状症状症状毒性毒性毒性毒性毒性毒性

さらに関連する動画

05:18

Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome

Published on: May 26, 2023

1.9K

12:59

A Study of the Complexation of MercuryII with Dicysteinyl Tetrapeptides by Electrospray Ionization Mass Spectrometry

Published on: January 8, 2016

8.4K

関連する概念動画

01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...

01:26

Toxic Reactions: Overview

2.2K

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...

2.2K

01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...

01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...

01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...

01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...

関連する実験動画